| Literature DB >> 31694682 |
Barbara A Myers1, Yegan Pillay2, W Guyton Hornsby3, Jay Shubrook4, Chandan Saha1, Kieren J Mather1, Karen Fitzpatrick3, Mary de Groot5.
Abstract
BACKGROUND: Participant recruitment for clinical trials is a significant challenge for the scientific research community. Federal funding agencies have made continuation of funding of clinical trials contingent on meeting recruitment targets. It is incumbent on investigators to carefully set study recruitment timelines and resource needs to meet those goals as required under current funding mechanisms. This paper highlights the cost, labor, and barriers to recruitment for Program ACTVE II, a successful multisite randomized controlled trial of behavioral treatments for depression in adults with type 2 diabetes, conducted in rural and urban settings in three states.Entities:
Keywords: Clinical trial; Depression; Diabetes; Study recruitment
Mesh:
Year: 2019 PMID: 31694682 PMCID: PMC6836437 DOI: 10.1186/s13063-019-3712-x
Source DB: PubMed Journal: Trials ISSN: 1745-6215 Impact factor: 2.279
Study exclusion criteria
| Medical exclusions | Psychiatric exclusions |
|---|---|
• Age 18 years or older • Not able to walk • Currently pregnant or planning on becoming pregnant in the next year • History of diabetic ketoacidosis • Continuous insulin therapy since type 2 diabetes diagnosis • History of stroke or transient ischemic attack • Recent cardiac event (diagnosed angina, PTCA, any cardiac intervention for CAD or tachydysrhythmias in the past 6 months) • Laser surgery for proliferative retinopathy in the past 6 months • Aortic stenosis or other sever valvular heart disease or atrial fibrillation • Lower limb amputation • Asensory proliferative retinopathy • Uncontrolled hypertension • Current use of daytime oxygen (severe COPD) • Class III or IV heart failure • Diagnosis of type 2 diabetes < 1 year | • No diagnosis of current MDD • Active suicidal ideation or history of suicide attempt • Bipolar depression • Evidence of psychotic symptoms or history of psychotic disorder • Current substance abuse or dependence • Co-morbid anxiety or eating disorders where MDD is not the primary presentation • If on antidepressant medication, stable dose and usage for at least 6 weeks • Current therapy for MDD by a mental health professional |
PTCA Percutaneous transluminal coronary angioplasty, CAD Coronary artery disease, MDD major depressive disorder, COPD chronic obstructive pulmonary disease
Fig. 1Enrollment flow chart: Inbound vs Outbound
Screening and enrollment numbers and costs
Fig. 2Cumulative participant enrollment
Study limitations and potential biases
| Study limitations | Potential biases |
|---|---|
• Staff effort may be underestimated due to inconsistent logging of time • Reported costs have not been adjusted for inflation | • Stringent study exclusion criteria increased recruitment effort and costs • Recruitment of people with MDD made recruitment more difficult • Some staff members were not consistent in logging time spent on tasks, resulting in some estimation of effort |
Key points
• Recruitment to clinical trials is challenging • Recruitment planning during the grant application phase needs to reflect a realistic timeline and adequate budget • Recruitment efforts for Program ACTIVE II cost an average of $1358 for each of the 140 enrolled participants over four years • Sufficient time, funds, and funder support as well as flexibility and adaptation are necessary to meet recruitment goals |